• BX Home
  • Business of Biotechnology: Blog [Page 7]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

BUSINESS OF BIOTECHNOLOGY

They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.

Business of Biotechnology is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 1,248 news and 4,696 blog items. Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from like-minded professionals.

Blogs

Recent blog posts on this topic.

Drug Patent Expirations for Apr 3 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 14 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 16 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

See you at BIO in Chicagomore

Copyright © thinkBiotech I will be at BIO 2013, representing BiotechBlog, the Journal of Commercial Biotechnology, and...

Swiss biotech raises $50.6M to further hearing-loss drugsmore

Swiss biotech Auris Medical has raised $50.6 million in a Series C round of financing to advance its two major...

Bristol-Myers forges discovery pact with rising RNA drug playermore

Santaris Pharma has found another major pharma partner for its RNA drug platform. Bristol-Myers Squibb ($BMY) has...

Johnson & Johnson tops pharma rivals in 10-year test of R&D pr...more

A new analysis provides some explanation for why Johnson & Johnson ($JNJ) and other companies live at the top of...

Analysis: 2012 life sciences VC fundraising and new bets shrivelmore

Brace for more dour figures on venture investment in biotech. Despite some bright spots in life sciences venture...

Drug Patent Expirations for Apr 16 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Roche, billionaire-backed biotech partner on hep C drug in Chinamore

Roche ($RHHBY) and the biotech startup Ascletis have joined forces to advance Roche's experimental drug danoprevir for...

FDA questions benefits of GSK's respiratory contender Breomore

As GlaxoSmithKline ($GSK) gears up for an advisory committee meeting on Breo, the British drug giant can expect to face...

Sanofi CEO fires surprise torpedo at Alzheimer's drug researchmore

Count Sanofi ($SNY) out of the wild chase to develop Alzheimer's drugs, at least while the best line of attack against...

Drug Patent Expirations for Mar 25 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 26 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 3 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 14 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 22 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 25 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 26 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 3 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

The SEC’s enforcement programme on biotechnology’s communications with...more

Copyright © thinkBiotech This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology...

Portola rolls out $115M IPO plan as more biotech outfits go publicmore

The list of biotechs going public grows longer. With public investors warming to biotech IPOs, Portola Pharmaceuticals...

Pfizer to move hundreds of workers to heart of Boston-area R&D hubmore

There's Cambridge, and then there's Kendall Square, arguably the heart of all biotech activity in the Boston area.

Biotech Chimerix shines in IPO debut as interest grows in antiviral dr...more

Chimerix sped out of the IPO gate on Thursday. The Durham, NC-based drug developer's ($CMRX) stock soared on its first...

Firm ranks top 5 biotech deals in evolving pharma R&D landscapemore

With pharma groups hunting for external innovation, an analysis shows a spike in early-stage biotech partnerships...

Top Sources: Business of Biotechnology

  • Biotech Blog
  • News
  • Health Beat
  • frontendofinnovation.blogspot.com
  • Nature Biotechnology
  • The Biotech Weblog
  • policyinnovations.org
  • Science Progress
  • LinkedIn Answers: Technology
  • World Pharma News / Published News

Most Active Users in this Topic

see all contributors in Business of Biotechnology

Featured White Papers

Post a Job

Jobs in this Topic

SOFTWARE ENGINEER at exciting biotech company! Adaptive Biotechnologies | Seattle, WA
Posted: Apr 19
Process Sciences Associate Drug Product Regeneron | Rensselaer, NY
Posted: May 8
Research Associate - Biotechnology William Blair Company, L.L.C | New York, NY
Posted: Apr 19

Report comment contains invalid characters. ()
cancel
Search Cancel